ATE175358T1 - Behandlung des prämenstruellen oder späten lutealsphase-syndroms - Google Patents

Behandlung des prämenstruellen oder späten lutealsphase-syndroms

Info

Publication number
ATE175358T1
ATE175358T1 AT88910336T AT88910336T ATE175358T1 AT E175358 T1 ATE175358 T1 AT E175358T1 AT 88910336 T AT88910336 T AT 88910336T AT 88910336 T AT88910336 T AT 88910336T AT E175358 T1 ATE175358 T1 AT E175358T1
Authority
AT
Austria
Prior art keywords
treatment
premenstrual
luteal phase
phase syndrome
late luteal
Prior art date
Application number
AT88910336T
Other languages
English (en)
Inventor
Richard J Wurtman
Judith J Wurtman
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26809210&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE175358(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/244,944 external-priority patent/US4971998A/en
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE175358T1 publication Critical patent/ATE175358T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Conversion Of X-Rays Into Visible Images (AREA)
AT88910336T 1987-10-22 1988-10-21 Behandlung des prämenstruellen oder späten lutealsphase-syndroms ATE175358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11177187A 1987-10-22 1987-10-22
US07/244,944 US4971998A (en) 1987-10-22 1988-09-15 Methods for treating the premenstrual or late luteal phase syndrome

Publications (1)

Publication Number Publication Date
ATE175358T1 true ATE175358T1 (de) 1999-01-15

Family

ID=26809210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88910336T ATE175358T1 (de) 1987-10-22 1988-10-21 Behandlung des prämenstruellen oder späten lutealsphase-syndroms

Country Status (5)

Country Link
EP (1) EP0386117B1 (de)
JP (1) JP2938463B2 (de)
AT (1) ATE175358T1 (de)
DE (1) DE3856295T2 (de)
WO (1) WO1989003692A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011688A (en) * 1989-02-02 1991-04-30 Calam Henry D Liquid composition for the relief of premenstrual and menstrual discomforts
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
CA2039103A1 (en) * 1990-03-29 1991-09-30 David Wayne Robertson Improvements in and relating to the selective occupation of serotonin 1c receptors
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5455254A (en) * 1991-02-15 1995-10-03 Mondadori; Cesare Substituted benzofuranylpiperidine as a nootropic agent
ES2087497T3 (es) * 1991-02-15 1996-07-16 Ciba Geigy Ag Benzofuranilpiperidina substituida como nootropico.
FR2685204B1 (fr) * 1991-12-19 1995-06-16 Palmer Research Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
DE69429895T2 (de) * 1993-06-28 2002-08-29 American Home Products Corp., Madison Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten
ATE199829T1 (de) * 1994-06-03 2001-04-15 Thejmde Trust Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
NZ508310A (en) * 1998-04-24 2005-03-24 Scarista Ltd Pharmaceutical composition containing folate precursor and a serotonin uptake inhibitor or a noradrenaline reuptake inhibitor useful for treating depression
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
EP2305229A1 (de) * 2001-12-05 2011-04-06 Teva Women's Health, Inc. Orale Verhütungsmittel zum Verhindern einer Schwangerschaft und Reduzierung von prämenstruellen Symptomen
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
JP2016516732A (ja) 2013-03-18 2016-06-09 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ メタクリル酸及びメタクリル酸エステルの製造方法
EP3608305A1 (de) 2018-08-10 2020-02-12 Röhm GmbH Verfahren zur herstellung von methacrylsäure oder methacrylsäureestern

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4309445A (en) * 1980-06-16 1982-01-05 Massachusetts Institute Of Technology d-Fenfluramine for modifying feeding behavior
GB2129299A (en) 1982-11-09 1984-05-16 Alec James Coppen Pharmaceutical compositions
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
US4649161A (en) 1986-06-16 1987-03-10 Massachusetts Institute Of Technology Method for treating depression with d-fenfluramine

Also Published As

Publication number Publication date
JP2938463B2 (ja) 1999-08-23
DE3856295T2 (de) 1999-06-17
DE3856295D1 (de) 1999-02-18
EP0386117B1 (de) 1999-01-07
JPH03500884A (ja) 1991-02-28
EP0386117A1 (de) 1990-09-12
WO1989003692A1 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
ATE175358T1 (de) Behandlung des prämenstruellen oder späten lutealsphase-syndroms
ATE128864T1 (de) Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak.
DE3483040D1 (de) Maschinelesbares dokument und dessen behandlung.
NO900837D0 (no) Hylster til roekeartikler og fremgangsmaate til dets behandling.
DE69202207D1 (de) Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
IT8021233A0 (it) Procedimento per deodorare e/o disacidare composti organici altobollenti, in particolare olii alimentari.
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
NO900358D0 (no) Fremgangsmaate og innretning for behandling av faststoff-gass-blandinger som skal pumpes.
PT66089A (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect,application of same for the preparation of pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
IT7926382A0 (it) Trattamento del gas di spurgo nella sintesi della ammoniaca.
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
NL7607335A (nl) Werkwijze voor de bereiding van 4,4,6-trime- thyl-2-cyclohexenon alsmede de toepassing daarvan in reukmiddelmengsels.
CA2002182A1 (en) Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use
NL7612682A (nl) Werkwijze en inrichting voor de warmtebehande- ling van waren, alsmede waren behandeld onder toepassing van de werkwijze.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
IT8420682A0 (it) Procedimento per il trattamento di articoli di maglieria.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
ATE122886T1 (de) Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee